2013 annual financial data
Altimmune 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -40.02%.
Operating income was -10,839,208 USD and net income was -11,718,353 USD.
Operating cash flow was -7,168,204 USD.
Get free Altimmune email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 17,912,607 USD
- Operating income
- -10,839,208 USD
- Net income
- -11,718,353 USD
- Operating cash flow
- -7,168,204 USD